Financial Performance - The company's operating revenue for Q3 2021 was ¥95,762,282.83, representing a 1.00% increase year-over-year, and a total revenue of ¥390,059,005.95 for the year-to-date, which is a 41.23% increase compared to the same period last year[3] - The net profit attributable to shareholders for Q3 2021 was ¥17,689,655.98, a significant increase of 53.88% year-over-year, with a year-to-date net profit of ¥46,727,266.79, reflecting a 45.03% increase[3] - The basic earnings per share for Q3 2021 was ¥0.07, up 40.00% from the same period last year, while the diluted earnings per share also stood at ¥0.07, with a year-to-date figure of ¥0.19, which is a 46.15% increase[3] - Total operating revenue for the current period reached ¥390,059,005.95, a significant increase of 41.2% compared to ¥276,182,122.36 in the previous period[27] - Net profit for the current period was ¥49,958,913.78, representing a 40.9% increase from ¥35,453,241.01 in the same period last year[30] - The net profit attributable to the parent company was ¥46,727,266.79, compared to ¥32,218,884.72 in the previous period, reflecting a growth of 45.1%[30] - Basic and diluted earnings per share both stood at ¥0.19, up from ¥0.13 in the previous period[30] - The company reported a total profit of ¥52,662,829.07, compared to ¥39,276,169.22 in the previous period, marking a growth of 34.5%[27] Assets and Liabilities - The company's total assets at the end of Q3 2021 were ¥1,126,783,960.31, marking a 4.00% increase from the end of the previous year[3] - As of September 30, 2021, the total current assets amounted to ¥761,524,498.46, an increase from ¥743,385,821.43 as of December 31, 2020, reflecting a growth of approximately 2%[18] - The company's non-current assets totaled ¥365,259,461.85, an increase from ¥340,054,577.39, representing a growth of about 7.4%[18] - Total liabilities as of September 30, 2021, were ¥119,620,508.80, up from ¥107,035,861.09, marking an increase of about 11.5%[22] - The total current liabilities amounted to ¥83,656,760.44, an increase from ¥72,942,889.73, reflecting a growth of approximately 14.5%[22] - The total equity attributable to shareholders increased to ¥919,646,202.24 from ¥892,118,935.45, reflecting a growth of approximately 3.1%[22] Cash Flow - The cash flow from operating activities showed a net outflow of ¥61,313,303.61 year-to-date, indicating a significant decline of 523.49% compared to the previous year[3] - Cash flow from operating activities showed a net outflow of ¥61,313,303.61, worsening from a net outflow of ¥9,833,940.45 in the prior period[34] - The net cash flow from investing activities was -$8,800,949.05, a significant improvement from -$17,562,637.01 in the previous period, indicating a reduction in cash outflow[37] - The net cash flow from financing activities was -$11,406,259.74, slightly better than -$12,482,817.71 in the prior period, suggesting improved cash management[37] - The net increase in cash and cash equivalents was -$81,520,512.40, worsening from -$39,879,395.17, indicating challenges in cash generation[37] - The ending balance of cash and cash equivalents decreased to $65,290,644.47 from $87,519,272.07, showing a decline in liquidity[37] Investments and Receivables - The company's investment income increased by 394.62% year-over-year, attributed to profit growth from joint ventures[7] - Other receivables grew by 135.34% compared to the beginning of the period, primarily due to increases in petty cash and insurance loans[7] - The company's contract liabilities increased by 67.74% year-over-year, driven by revenue growth from the main business and its subsidiary[7] - The company reported a decrease of 47.25% in other income year-over-year, mainly due to reduced inputs as major national projects entered the acceptance phase[7] - Accounts receivable increased to ¥183,135,617.67 from ¥166,372,163.23, showing a growth of approximately 10%[18] - Inventory rose to ¥335,135,846.31 from ¥290,770,529.59, indicating an increase of around 15.2%[18] - The company reported a significant increase in prepayments to ¥121,141,007.69 from ¥84,410,324.89, which is an increase of around 43.5%[18] Expenses - Total operating costs amounted to ¥372,659,745.39, up 43.6% from ¥259,383,332.97 in the prior period[27] - Research and development expenses increased to ¥33,931,455.96, up 29.8% from ¥26,139,801.27 in the previous period[27] - Tax expenses for the current period were ¥2,703,915.29, down from ¥3,822,928.21 in the previous period, indicating a decrease of 29.3%[27] Other Information - The weighted average return on net assets was 1.93% for Q3 2021, an increase of 0.59% compared to the previous year[3] - The company did not require adjustments to the beginning balance sheet items under the new leasing standards, as no relevant transactions occurred[38] - The third quarter report was not audited, which may affect the reliability of the financial data presented[41]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥294,296,723.12, representing a 62.26% increase compared to ¥181,368,191.14 in the same period last year[27] - The net profit attributable to shareholders of the listed company was ¥29,037,610.81, up 40.12% from ¥20,723,201.35 in the previous year[27] - The net profit after deducting non-recurring gains and losses was ¥26,858,499.21, reflecting a 61.27% increase from ¥16,654,818.72 year-on-year[27] - The basic earnings per share increased to ¥0.12, a rise of 33.33% compared to ¥0.09 in the same period last year[27] - The company's revenue for the reporting period reached ¥294,296,723.12, a 62.26% increase compared to ¥181,368,191.14 in the same period last year, primarily due to bulk deliveries of certain products and increased revenue from subsidiary Yuheng Optics[53] - The company's total revenue for the reporting period reached ¥294,296,723.12, representing a year-on-year increase of 62.26% compared to ¥181,368,191.14 in the same period last year[56] - The net profit for the first half of 2021 was ¥32,038,537.99, representing a 45.0% increase from ¥22,105,327.00 in the first half of 2020[182] - The company reported a total comprehensive income for the period reached 32,038,537.99, compared to 22,105,327.00 in the previous period, reflecting a significant increase[186] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,125,149,174.12, which is a 3.85% increase from ¥1,083,440,398.82 at the end of the previous year[27] - The company's total assets increased to ¥939,793,499.05, compared to ¥917,530,315.82 at the end of the previous period, marking a growth of 2.9%[176] - The company's total liabilities reached CNY 135,906,098.40, up from CNY 107,035,861.09, reflecting an increase of approximately 27.0%[166] - The total current liabilities increased to ¥70,679,897.21 from ¥50,978,269.51, reflecting a rise of 38.5%[176] Cash Flow - The net cash flow from operating activities was -¥56,869,259.96, a significant decline of 307.18% compared to -¥13,966,613.76 in the same period last year[27] - The cash flow from operating activities was negative at -56,869,259.96, worsening from -13,966,613.76 in the previous period[198] - The net cash flow from investment activities improved by 36.46%, amounting to -¥7,224,689.82 compared to -¥11,370,646.61, due to receiving dividends from associated enterprises[53] Research and Development - Research and development expenses rose by 23.66% to ¥25,397,752.80 from ¥20,538,587.41, reflecting the company's commitment to innovation[53] - The company holds a total of 53 patents, including 24 utility models and 29 invention patents, indicating a strong focus on technological innovation[48] - Research and development expenses for the first half of 2021 were ¥25,397,752.80, compared to ¥20,538,587.41 in the same period last year, an increase of 23.5%[179] Market Position and Strategy - The company is a key player in the domestic optoelectronic measurement and control instrument manufacturing industry, with a focus on military products and significant involvement in national major engineering projects[37] - The company emphasizes independent research and innovation, aiming to maximize value through customer satisfaction and continuous improvement[37] - The company plans to enhance market expansion through innovation and product optimization to mitigate market risks[71] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[189] Shareholder Information - The total number of shares after the recent changes is 240,000,000, maintaining a 100% ownership structure[130] - The largest shareholder, the Chinese Academy of Sciences, holds 101,754,784 shares, accounting for 42.40% of total shares[140] - The total number of common shareholders at the end of the reporting period is 32,706[139] - There were no changes in the number of shares held by major shareholders during the reporting period[139] Compliance and Governance - The company faced no significant risks that could materially affect its production and operation during the reporting period[7] - The company reported no significant environmental violations or penalties during the reporting period[81] - The company has established an emergency response plan for environmental pollution incidents and conducts annual drills[81] - The semi-annual financial report has not been audited[93] Miscellaneous - The company plans not to distribute cash dividends or issue bonus shares during this reporting period[7] - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[77] - The company has not engaged in any significant mergers or acquisitions during the reporting period[87] - The company has not initiated any targeted poverty alleviation work during the reporting period[84]

Financial Performance - The company's operating revenue for Q1 2021 was ¥143,104,677.95, representing an increase of 88.72% compared to the same period last year[8]. - The net profit attributable to shareholders for Q1 2021 was ¥15,969,329.32, a year-on-year increase of 41.12%[8]. - The net profit after deducting non-recurring gains and losses was ¥14,924,810.90, reflecting a growth of 70.85% year-on-year[8]. - The basic earnings per share for Q1 2021 were ¥0.07, a 40.00% increase from the previous year[8]. - Total operating revenue for the first quarter reached ¥143,104,677.95, a significant increase from ¥75,829,996.11 in the previous year, representing an increase of approximately 88.5%[56]. - The net profit for the current period is CNY 16,711,676.16, compared to CNY 11,384,602.06 in the previous period, reflecting an increase of about 47.0%[62]. - The operating profit for the current period is CNY 17,855,832.53, up from CNY 12,063,526.52, indicating a growth of around 48.5%[62]. - Total comprehensive income increased to ¥14,605,406.06 from ¥11,208,616.23, representing a growth of approximately 30.5% year-over-year[72]. - Basic and diluted earnings per share rose to ¥0.06, up from ¥0.05, indicating a 20% increase[72]. Cash Flow and Assets - The net cash flow from operating activities decreased by 180.03%, amounting to -¥16,166,654.19, primarily due to increased material procurement and payments[20]. - Cash inflow from operating activities totaled ¥146,484,472.16, compared to ¥134,973,882.04 in the previous period, marking an increase of about 8.8%[73]. - Cash outflow for purchasing goods and services was ¥101,941,616.77, significantly higher than ¥61,408,930.39, reflecting a 65.7% increase[76]. - Cash and cash equivalents at the end of the period decreased to ¥126,719,543.49 from ¥136,058,613.83, a decline of about 6.3%[79]. - The company reported a net cash outflow from financing activities of -¥259,770.00, compared to -¥5,734,457.90 in the previous period, indicating a significant reduction in cash outflow[79]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,100,850,935.16, a 1.61% increase from the end of the previous year[8]. - The net assets attributable to shareholders at the end of the reporting period were ¥908,088,264.77, up 1.79% from the previous year[8]. - The total liabilities of the company were reported at ¥61,524,851.90, a decrease from ¥64,617,793.94 in the previous period, indicating a reduction of approximately 4.5%[55]. - The total equity attributable to shareholders of the parent company increased to ¥908,088,264.77 from ¥892,118,935.45, reflecting a growth of about 1.8%[48]. - The total assets of the company as of March 31, 2021, amounted to ¥929,042,779.84, compared to ¥917,530,315.82 in the previous period, showing a growth of about 1.7%[55]. Operational Highlights - The company’s subsidiary, Yuheng Optics, achieved a revenue growth of 131.36% by seizing opportunities in product import substitution[20]. - Research and development expenses increased to CNY 12,022,251.68 from CNY 10,245,740.70, marking a rise of approximately 17.4%[62]. - The total operating costs for the current period are CNY 132,449,177.45, compared to CNY 77,116,995.90 in the previous period, which is an increase of approximately 71.8%[62]. - The company reported investment income of CNY 6,439,421.34, significantly higher than CNY 246,953.96 in the previous period, indicating a substantial increase[62]. Compliance and Commitments - The company has made commitments to avoid competition in the military product sector, ensuring that all military products are used solely for research purposes[24]. - The company has committed to fulfilling its promises to minority shareholders in a timely manner[24]. - There were no violations of external guarantees during the reporting period[31]. - The company has not engaged in any securities or derivative investments during the reporting period[25][28]. - The company did not undergo an audit for the first quarter report, which may affect the reliability of the financial data presented[86].

Financial Performance - The company's operating revenue for 2020 was CNY 440,745,975.42, representing a 9.59% increase compared to CNY 402,192,805.25 in 2019[22]. - The net profit attributable to shareholders for 2020 was CNY 52,126,086.63, up 7.96% from CNY 48,282,866.43 in 2019[22]. - Basic earnings per share for 2020 increased to CNY 0.22, a 10.00% rise from CNY 0.20 in 2019[22]. - The net profit after deducting non-recurring gains and losses for 2020 was CNY 41,030,100.70, an increase of 11.04% from CNY 36,950,942.06 in 2019[22]. - Total revenue for the year reached ¥440,945,976.42, with a significant increase in Q4 revenue to ¥164,563,853.06, representing a 73.5% increase compared to Q3[27]. - Net profit attributable to shareholders for the year was ¥51,127,086.63, with Q4 net profit reaching ¥19,907,201.91, marking a 73.5% increase from Q3[27]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year, representing a 15% year-over-year growth[41]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the fiscal year, representing a growth of 15% year-over-year[47]. Cash Flow and Investments - The net cash flow from operating activities decreased by 19.36% to CNY 58,027,202.37 from CNY 71,956,292.94 in 2019[22]. - The net cash flow from operating activities for Q4 was ¥67,861,142.82, a substantial recovery from a negative cash flow of ¥34,166,242.92 in Q2[27]. - Investment cash inflow surged by 734.07% to ¥132,602,470.03, while investment cash outflow increased by 591.26% to ¥156,467,496.57[77]. - The company's cash and cash equivalents net increase was ¥19,640,489.63, a decrease of 61.65% compared to the previous year[77]. - The total investment amount for the reporting period was ¥9,000,000, representing a 17.65% increase compared to ¥7,650,000 in the same period last year[85]. Market and Product Development - The company focuses on the R&D and production of optoelectronic measurement and control instruments, with key products including high-precision optical measurement devices and new medical instruments[35]. - New product development includes the launch of a multifunctional vision testing device, which is expected to enhance market competitiveness[42]. - The company is expanding its market presence, targeting a 25% increase in sales in international markets over the next year[41]. - The company is exploring strategic acquisitions to enhance its technological capabilities and market reach, with a focus on companies in the optical and medical device sectors[41]. - The company has secured 12 new patents, including advancements in optical instruments and image recognition technology, which will support future product innovation[42]. Operational Strategy and Future Outlook - The company plans to distribute a cash dividend of CNY 0.8 per 10 shares, totaling CNY 19,200,000 based on 240,000,000 shares[6]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[41]. - The company aims to improve operational efficiency by implementing new manufacturing processes, which are expected to reduce production costs by 15%[41]. - The company is committed to sustainability initiatives, with plans to reduce carbon emissions by 30% over the next five years[41]. - The company will enhance its quality system and implement quality supervision to meet annual quality targets in 2021[95]. Corporate Governance and Compliance - The company has established a comprehensive corporate governance structure to ensure fair treatment of all shareholders[158]. - The company strictly adheres to environmental protection laws and has implemented effective pollution control measures[159]. - The company has not engaged in any major litigation or arbitration matters during the reporting period[126]. - The company has not implemented any stock incentive plans or employee shareholding plans during the reporting period[128]. - The company has not faced any delisting situations following the annual report disclosure[125]. Shareholder Information - The total number of shares is 240,000,000, with 99.99% being unrestricted shares[168]. - The largest shareholder, the Chinese Academy of Sciences, holds 42.40% of the shares, totaling 101,754,784[176]. - The total number of shareholders increased from 31,622 to 32,690 during the reporting period[173]. - The company has not reported any changes in the actual controller during the reporting period[184]. - The top ten shareholders did not engage in repurchase transactions during the reporting period[182].

Financial Performance - Operating revenue for the period reached ¥94,813,931.22, reflecting an 11.96% year-on-year growth[7] - Net profit attributable to shareholders was ¥11,495,683.37, a significant increase of 34.30% compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥10,176,360.48, up 47.66% year-on-year[7] - Basic earnings per share were ¥0.05, representing a 25.00% increase compared to the previous year[7] - The total operating revenue for the third quarter was CNY 94,813,931.22, an increase from CNY 84,684,321.47 in the same period last year, representing a growth of approximately 12.6%[52] - The net profit for the current period is CNY 13,347,914.01, representing an increase of 40.5% compared to CNY 9,504,802.27 in the previous period[58] - The operating profit for the current period is CNY 15,110,764.02, up 21.8% from CNY 12,401,207.30 in the previous period[58] - The total comprehensive income for the current period is CNY 13,347,914.01, an increase of 40.5% from CNY 9,504,802.27 in the previous period[60] - Net profit for the current period was ¥35,453,241.01, compared to ¥30,676,726.87 in the previous period, reflecting a growth of approximately 15.00%[74] - The total comprehensive income for the current period was ¥35,453,241.01, up from ¥30,676,726.87 in the previous period, marking an increase of around 15.00%[74] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,081,195,814.12, representing a 3.92% increase compared to the end of the previous year[7] - The total assets amounted to approximately CNY 1,081,195,814.12 at the end of the reporting period, an increase from CNY 1,040,450,813.18 at the end of the previous period[38] - The total liabilities increased to CNY 132,529,807.57 from CNY 115,238,047.64, reflecting a rise of about 15.5%[44] - The balance of accounts payable was CNY 32,036,474.72 at the end of the reporting period, compared to CNY 27,119,616.99 at the end of the previous period[38] - The balance of notes receivable decreased by 51.50% at the end of the reporting period, mainly due to the maturity and payment of acceptance bills by the company and its subsidiaries[21] - The cash balance at the end of the reporting period decreased by 31.30% compared to the beginning of the period, primarily due to increased cash payments for investments, repayment of bank loans, and a decrease in operating cash flow[21] - The total equity attributable to shareholders of the parent company rose to CNY 868,913,796.08, up from CNY 848,694,911.36, indicating an increase of approximately 2.6%[44] Cash Flow - The net cash flow from operating activities was ¥4,132,673.31, showing a decline of 91.41% compared to the same period last year[7] - Cash inflow from operating activities totaled approximately ¥324.53 million, compared to ¥292.83 million in the previous period, representing an increase of about 10.8%[87] - The net cash flow from operating activities was negative at approximately -¥9.83 million, a significant decline from a positive ¥18.33 million in the previous period[87] - Cash outflow from investing activities was approximately ¥22.42 million, up from ¥16.41 million in the previous period, indicating an increase of about 36.5%[89] - The total cash and cash equivalents at the end of the period stood at approximately ¥87.52 million, a decrease from ¥84.39 million in the previous period[89] - The company reported a significant increase in cash received from sales of goods and services, totaling approximately ¥312.32 million, compared to ¥265.28 million in the previous period, marking an increase of about 17.7%[87] - The company experienced a decrease in cash flow from operating activities, with cash outflows totaling approximately ¥334.37 million, compared to ¥274.49 million in the previous period, indicating an increase of about 22%[87] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 37,003[12] - The largest shareholder, the Chinese Academy of Sciences Changchun Institute of Optics, holds 42.65% of the shares, totaling 102,354,784 shares[12] Government Support and Expenses - The company received government subsidies amounting to ¥8,210,908.53 during the reporting period[7] - Research and development expenses decreased to CNY 5,601,213.86, down 55.1% from CNY 12,426,580.24 in the previous period[58] - The company reported a significant decrease in tax expenses, with current period taxes at ¥3,822,928.21 compared to ¥3,182,445.89 in the previous period, indicating a strategic tax management approach[74] Future Outlook - The company plans to expand its market presence and invest in new product development in the upcoming quarters[75] - The financial data reflects a challenging cash flow situation, necessitating strategic financial management moving forward[97]

Financial Performance - The company's operating revenue for the first half of 2020 was ¥181,368,191.14, a decrease of 0.10% compared to the same period last year[22]. - The net profit attributable to shareholders was ¥20,723,201.35, representing an increase of 2.09% year-on-year[22]. - The net profit after deducting non-recurring gains and losses was ¥16,654,818.72, which is a significant increase of 21.81% compared to the previous year[22]. - Basic earnings per share rose to ¥0.09, reflecting a 12.50% increase from ¥0.08 in the previous year[22]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion yuan in the last quarter, representing a 15% year-over-year growth[41]. - The company has set a future outlook with a revenue target of 1.5 billion yuan for the next quarter, reflecting a 25% growth expectation[41]. - The company reported a total of 3,710.37 million yuan in actual sales to related parties during the reporting period, against an expected amount of 16,000 million yuan for the year[101]. - The total profit amounted to 19,252,205.10, which is a decrease of around 10.4% from 21,606,538.62 in the prior period[198]. Cash Flow and Assets - The net cash flow from operating activities improved to -¥13,966,613.76, a 53.13% increase from -¥29,798,307.81 in the same period last year[22]. - The company’s cash and cash equivalents decreased by 30.22% to CNY -31.05 million, reflecting challenges in cash flow management[56]. - Cash and cash equivalents increased to 96,347,602.26, making up 9.16% of total assets, up from 5.10% in the previous year[65]. - Accounts receivable decreased to 160,436,586.97, representing 15.26% of total assets, down from 21.14% year-on-year[65]. - Inventory rose to 290,262,097.76, accounting for 27.61% of total assets, an increase from 25.40% in the previous year[65]. - The total amount of prepayments increased to ¥111,987,302.35 from ¥81,929,970.55, marking a rise of approximately 36.6%[168]. - Total assets at the end of the reporting period were ¥1,051,313,800.54, an increase of 1.04% from the end of the previous year[22]. Research and Development - Research and development expenses increased by 39.46% to CNY 20.54 million, primarily due to expenses related to national projects[56]. - The company emphasizes independent research and innovation, aiming to enhance customer value and achieve sustainable operations[32]. - The company holds 13 patents related to optical technology, indicating a strong commitment to innovation and R&D[41]. - The company is committed to technological research and development as a priority for its mission of "strengthening the military through technology"[32]. Market Position and Strategy - The main business activities include the research, production, and sales of optoelectronic measurement and control instruments, optical materials, and grating encoders, with a focus on military products[32]. - The company is a key player in the domestic optoelectronic measurement and control instrument manufacturing industry, holding complete military qualifications[32]. - The company has participated in numerous national major engineering projects, reinforcing its position in the defense optoelectronic measurement field[32]. - The company is expanding its market presence by entering three new regions, aiming to increase market share by 10% in the next fiscal year[41]. - The company has completed a strategic acquisition of a smaller tech firm, which is projected to contribute an additional 200 million yuan in revenue annually[41]. Risks and Challenges - The company faces potential risks in its future operations, which are discussed in detail in the report[5]. - The company faces risks including market risks and talent retention risks, with strategies in place to mitigate these challenges[78]. - The company has not experienced any major litigation or arbitration matters during the reporting period[90]. - The company has not faced any penalties or rectification issues during the reporting period[91]. Environmental and Social Responsibility - The company has established an emergency response plan for environmental pollution incidents and conducts annual drills[121]. - The company has installed online monitoring facilities for wastewater treatment to ensure no excess wastewater is discharged[121]. - The company reported a total emission of hexavalent chromium at 0.001 tons and total nickel at 0.00088 tons, both meeting the pollution discharge standards[121]. Shareholder Information - The company has a total of 240,000,000 shares, with 99.99% being unrestricted shares[131]. - The largest shareholder, the Chinese Academy of Sciences Changchun Optical Precision Machinery and Physics Research Institute, holds 42.65% of the shares, totaling 102,354,784 shares[135]. - The company has a total of 38,968 common stock shareholders at the end of the reporting period[135].

证券代码：002338 证券简称：奥普光电 公告编号：2020-035 长春奥普光电技术股份有限公司 关于参加投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，长春奥普光电技术股份有限公司（以下 简称"公司"）将参加由吉林证监局、吉林省证券业协会、深圳市全景网络有限 公司共同举办的"提高公司质量 做受尊敬的上市公司--2020年吉林辖区上市公 司投资者网上集体接待日"活动，现将有关事项公告如下： 本次集体接待日活动将通过深圳市全景网络有限公司提供的互联网平台举 行，投资者可以登陆"全景·路演天下"网站（http://rs.p5w.net）参与公司 本次投资者集体接待日活动,时间为2020年8月21日（周五）15:30至17:00。 届时公司董事长孙守红先生、总经理兼董事会秘书高劲松先生、财务负责人 徐爱民先生将通过网络在线问答互动的形式，与投资者就公司治理、发展经营情 况、融资情况和可持续发展等投资者关注的问题进行交流。期间，公司高管将全 程在线，实时回答投资者的提问。 欢迎广大投资者积极参与。 特 ...

Financial Performance - The company's operating revenue for 2019 was CNY 402,192,805.25, representing a 4.53% increase compared to CNY 384,765,405.52 in 2018[22] - The net profit attributable to shareholders for 2019 was CNY 48,282,866.43, an increase of 18.34% from CNY 40,800,234.70 in 2018[22] - The net cash flow from operating activities reached CNY 71,956,292.94, a significant increase of 842.68% compared to CNY 7,633,163.38 in 2018[22] - The basic earnings per share for 2019 was CNY 0.20, up 17.65% from CNY 0.17 in 2018[22] - Total assets at the end of 2019 amounted to CNY 1,040,450,813.18, reflecting a 5.27% increase from CNY 988,317,380.89 at the end of 2018[22] - The net assets attributable to shareholders increased to CNY 848,694,911.36, a rise of 3.90% from CNY 816,807,643.36 in 2018[22] - The company reported a diluted earnings per share of CNY 0.20, consistent with the basic earnings per share[22] - The weighted average return on equity for 2019 was 5.79%, an increase from 5.10% in 2018[22] Revenue Breakdown - Total revenue for the year was 402,192,805.25 CNY, with a quarterly breakdown of 79,808,616.01 CNY in Q1, 101,745,364.49 CNY in Q2, 84,684,321.47 CNY in Q3, and 135,954,503.28 CNY in Q4[27] - Net profit attributable to shareholders was 48,282,866.43 CNY for the year, with quarterly figures of 9,491,379.05 CNY in Q1, 10,808,047.07 CNY in Q2, 8,559,929.77 CNY in Q3, and 19,423,510.54 CNY in Q4[27] - The net profit after deducting non-recurring gains and losses was 37,650,942.10 CNY for the year, with quarterly amounts of 5,964,635.44 CNY in Q1, 7,707,933.64 CNY in Q2, 6,891,669.64 CNY in Q3, and 16,386,703.34 CNY in Q4[27] - The net cash flow from operating activities was 72,055,493.94 CNY for the year, with a significant increase in Q3 (45,132,792.63 CNY) and Q4 (53,621,808.12 CNY) after a negative cash flow in Q1[27] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 0.5 per 10 shares, totaling CNY 12,000,000 based on 240,000,000 shares[5] - In 2019, the company distributed a cash dividend of 12 million RMB, accounting for 24.85% of the net profit attributable to shareholders[101] - The company plans to distribute a cash dividend of 12 million RMB for 2019, maintaining the same amount as in 2018, which also represented 24.85% of the net profit[101] Research and Development - The company is engaged in the research, production, and sales of optoelectronic measurement and control instruments, with a focus on military applications and high-tech products[35] - The company emphasizes independent research and innovation, aiming to enhance customer value and achieve sustainable operations[35] - The company has a strong emphasis on research and development, with several patents granted for innovative optical technologies[43] - Research and development expenses for 2019 were ¥41,601,614.35, representing 10.35% of total revenue, with a 9.83% increase compared to the previous year[74] - The number of R&D personnel increased by 13.73% to 265, representing 21.60% of the total workforce[75] Market and Product Strategy - The company aims to enhance its market presence through strategic partnerships and potential acquisitions in the optical industry[43] - The company is focused on expanding its product line in medical analysis instruments and laser technology[43] - The company aims to leverage its patented technologies to gain a competitive edge in the optical and medical device markets[43] - The company is focused on sustainability and efficiency in its production methods to reduce environmental impact[43] - The company aims to leverage technological innovation to enhance military-civilian integration and expand into civilian markets[93] Operational Efficiency - The company has strengthened its production management, resulting in improved project completion rates and production efficiency[57] - The company has optimized its KPI assessment system to better align performance with compensation and talent acquisition[58] - The company plans to maintain a balanced development of military and civilian products while focusing on high-tech manufacturing[93] - The company will implement comprehensive cost accounting and quantitative assessments to improve efficiency across all levels[93] - The company aims to reduce operational costs by 5% through efficiency improvements in the supply chain[198] Environmental Compliance - The company emphasizes environmental protection and resource efficiency in its operations[147] - The company strictly adheres to environmental protection laws and regulations, including the Environmental Protection Law of the People's Republic of China[149] - The company has established an emergency response plan for environmental pollution incidents and conducts annual drills to ensure preparedness[150] - The total discharge amount for hexavalent chromium is 0.002 tons and for total nickel is 0.000175 tons, indicating compliance with environmental standards[149] Shareholder Structure and Governance - The total number of shares is 240,000,000, with 99.99% being unrestricted shares[159] - The largest shareholder, the Changchun Institute of Optics, Fine Mechanics and Physics, holds 42.65% of the shares, totaling 102,354,784 shares[171] - The company has maintained a continuous audit relationship with Lixin Accounting Firm for 8 years, with an audit fee of 400,000 CNY for the current period[118] - The company reported no major litigation or arbitration matters during the reporting period[119] - The company has not faced any penalties or rectification issues during the reporting period[120] Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue growth of 20%[198] - The company plans to invest 100 million RMB in new technology research and development over the next fiscal year[198] - Future guidance includes maintaining a net profit margin of at least 10% for the upcoming fiscal year[198]

长春奥普光电技术股份有限公司 2020 年第一季度报告全文 UI……奥普光电 长春奥普光电技术股份有限公司 2020 年第一季度报告 2020 年 04 月 1 长春奥普光电技术股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人孙守红、主管会计工作负责人徐爱民及会计机构负责人(会计主 管人员)徐爱民声明：保证季度报告中财务报表的真实、准确、完整。 2 长春奥普光电技术股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |-----------------------------------------------------|--------------------------|--------------------------|------------- ...

Financial Performance - Operating revenue for the period was CNY 84,684,321.47, representing a year-on-year increase of 12.06%[7] - Net profit attributable to shareholders was CNY 8,559,929.77, up 9.50% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 6,891,669.64, a significant increase of 40.96% year-on-year[7] - The company's operating revenue for the current period is ¥49,751,972.16, an increase of 52.5% compared to ¥32,621,894.69 in the previous period[64] - The net profit for the current period is ¥6,799,081.43, a decrease from ¥8,584,139.41 in the previous period, representing a decline of 20.8%[64] - The total profit for the current period is ¥7,481,090.22, down from ¥8,584,139.41 in the previous period, indicating a decrease of 12.9%[64] - The total profit for the current period was ¥33,859,172.76, down from ¥36,985,287.17 in the previous period, indicating a decline of 8.56%[73] Cash Flow - Net cash flow from operating activities surged by 282.20% to CNY 48,132,792.63 compared to the same period last year[7] - The net cash flow from operating activities increased by 156.26% compared to the previous period, primarily due to a year-on-year increase in sales collections by the parent company[20] - Cash inflow from operating activities was 265,277,157.95, up from 215,945,808.47 in the previous period, indicating a growth of approximately 22.8%[86] - The net cash flow from operating activities was 18,334,484.82, a significant recovery from a negative cash flow of -32,588,263.67 in the previous period[89] - The total cash inflow from operating activities was 204,935,460.71, compared to 130,514,908.54 in the previous period, showing a growth of approximately 56.8%[95] Assets and Liabilities - Total assets increased by 4.00% to CNY 1,027,844,568.61 compared to the end of the previous year[7] - Current assets totaled CNY 731,752,157.65 as of September 30, 2019, compared to CNY 688,914,323.34 at the end of the previous year[32] - Total liabilities reached CNY 122,178,196.10, up from CNY 98,076,256.69 at the end of the previous year[40] - The company's equity attributable to shareholders amounted to CNY 831,281,420.69, an increase from CNY 816,807,643.36 at the end of the previous year[40] - The total liabilities increased to ¥97,092,227.66 from ¥70,573,081.20, reflecting a significant increase of 37.5%[48] Receivables and Inventory - Accounts receivable increased to CNY 191,773,556.06 from CNY 161,981,949.14 year-on-year[32] - Inventory stood at CNY 254,243,593.27, slightly up from CNY 250,166,900.09 at the end of the previous year[32] - Other receivables rose by 54.45%, attributed to increased insurance loans and prepayments for acquisition-related intermediary fees[18] - The company reported a significant increase in prepayments to CNY 115,090,688.53 from CNY 77,582,283.62 year-on-year[32] Research and Development - Research and development expenses increased to ¥12,426,580.24, compared to ¥10,649,204.54, indicating a growth of 16.7% year-over-year[52] - Research and development expenses increased to ¥7,793,169.58, compared to ¥6,753,353.44 in the previous period, reflecting a growth of 15.4%[64] - Research and development expenses increased to ¥27,153,542.85, compared to ¥26,103,876.44 in the previous period, reflecting a growth of 4.02%[70] Financial Obligations and Compliance - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[21] - There were no violations regarding external guarantees during the reporting period[25] - The third quarter report has not been audited[99] - The company has not applied new financial instrument standards or new leasing standards since 2019[99] - The company has not made retrospective adjustments for prior comparative data under new financial instrument or leasing standards since 2019[99]